CNS Drug Development Pipeline

NeurOp's CNS drug development pipeline is comprised of subunit-specific NMDA-based compounds for the treatment of serious disorders. Our most advanced compounds for depression and ischemia demonstrate efficacy in animal models with no apparent toxicity at therapeutic doses. The chart below shows our CNS drug development progress.

July 2017_NeurOp Development Pipeline